These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17490932)

  • 1. Granulomatous adenohypophysitis after interferon and ribavirin therapy.
    Tebben PJ; Atkinson JL; Scheithauer BW; Erickson D
    Endocr Pract; 2007; 13(2):169-75. PubMed ID: 17490932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central hypothyroidism and hypophysitis during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin.
    Ridruejo E; Christensen AF; Mando OG
    Eur J Gastroenterol Hepatol; 2006 Jun; 18(6):693-4. PubMed ID: 16702862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of peripheral facial nerve palsy with cryoglobulinemia and chronic thyroiditis occurring during interferon plus ribavirin therapy for chronic hepatitis C].
    Sumida Y; Kanemasa K; Fukumoto K; Yoshida N; Sakai K
    Nihon Shokakibyo Gakkai Zasshi; 2007 Jun; 104(6):815-21. PubMed ID: 17548949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C--a case report and review of the literature.
    Bolukbas C; Bolukbas FF; Kebdir T; Canayaz L; Dalay AR; Kilic G; Ovunc O
    Acta Gastroenterol Belg; 2005; 68(4):432-4. PubMed ID: 16432996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ischemic anterior optic neuropathy complicating interferon alpha-2a and ribavirin treatment for acute hepatitis C].
    Yaghi C; Baz P; Koussa S; Daniel F; Haddad F; Sayegh R
    Gastroenterol Clin Biol; 2005 May; 29(5):616-7. PubMed ID: 15980766
    [No Abstract]   [Full Text] [Related]  

  • 6. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
    McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
    N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hashimoto encephalopathy with pegylated interferon alfa-2b and ribavirin.
    Deutsch M; Koskinas J; Tzannos K; Vassilopoulos D; Mailis A; Tolis G; Hadziyannis S
    Ann Pharmacother; 2005 Oct; 39(10):1745-8. PubMed ID: 16159996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
    Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
    N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line therapy with daily versus thrice-weekly interferon alfa-2b plus ribavirin for chronic hepatitis C.
    Reiser M; Buggisch P; Grossmann J; Koop K; Wursthorn K; Schmiegel W
    Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1299-304. PubMed ID: 14624153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life-threatening thyrotoxicosis induced by combination therapy with PEG-interferon and ribavirin in chronic hepatitis C.
    Lin YQ; Wang X; Murthy MS; Agarwala S
    Endocr Pract; 2005; 11(2):135-9. PubMed ID: 15901529
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe interstitial pneumonitis secondary to pegylated interferon alpha-2b and ribavirin treatment of hepatitis C infection.
    Fuhrmann V; Kramer L; Bauer E; Laferl H; Tucek G; Dekan G; Schenk P
    Dig Dis Sci; 2004; 49(11-12):1966-70. PubMed ID: 15628735
    [No Abstract]   [Full Text] [Related]  

  • 12. Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for Hepatitis C.
    Yan KK; Dinihan I; Freiman J; Zekry A
    Intern Med J; 2008 Mar; 38(3):207-10. PubMed ID: 18290816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An extremely rare case of delusional parasitosis in a chronic hepatitis C patient during pegylated interferon alpha-2b and ribavirin treatment.
    Robaeys G; De Bie J; Van Ranst M; Buntinx F
    World J Gastroenterol; 2007 Apr; 13(16):2379-80. PubMed ID: 17511042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin.
    Buti M; Sanchez-Avila F; Lurie Y; Stalgis C; Valdés A; Martell M; Esteban R
    Hepatology; 2002 Apr; 35(4):930-6. PubMed ID: 11915041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin.
    Danilovic DL; Mendes-Correa MC; Chammas MC; Zambrini H; Marui S
    Clinics (Sao Paulo); 2011; 66(10):1757-63. PubMed ID: 22012048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcoid-like granulomatous orbital inflammation induced by interferon-alpha treatment.
    Hwang CJ; Gausas RE
    Ophthalmic Plast Reconstr Surg; 2008; 24(4):311-3. PubMed ID: 18645440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary hypophysitis: clinical-pathological correlations.
    Gutenberg A; Hans V; Puchner MJ; Kreutzer J; Brück W; Caturegli P; Buchfelder M
    Eur J Endocrinol; 2006 Jul; 155(1):101-7. PubMed ID: 16793955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2b and ribavirin for recurrent hepatitis C.
    Mukherjee S
    J Gastroenterol Hepatol; 2004 Jun; 19(6):723-4. PubMed ID: 15151639
    [No Abstract]   [Full Text] [Related]  

  • 19. Peginterferon-alpha(2b) and ribavirin.
    Ahn J; Flamm S
    Expert Rev Anti Infect Ther; 2004 Feb; 2(1):17-25. PubMed ID: 15482168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible myopathy during successful treatment with pegylated interferon and ribavirin for acute hepatitis C.
    Golstein PE; Delforge ML; Deviere J; Marcellin P
    J Viral Hepat; 2004 Mar; 11(2):183-6. PubMed ID: 14996354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.